RxSight, Inc.
RXST
$6.26
-$0.23-3.54%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -38.94M | -35.73M | -32.25M | -26.55M | -27.46M |
| Total Depreciation and Amortization | 3.27M | 2.89M | 3.18M | 3.22M | 3.58M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.06M | 23.18M | 21.13M | 17.58M | 16.10M |
| Change in Net Operating Assets | -4.89M | -9.00M | -8.88M | -10.72M | -9.16M |
| Cash from Operations | -15.51M | -18.66M | -16.82M | -16.47M | -16.95M |
| Capital Expenditure | -3.83M | -3.54M | -4.06M | -4.05M | -5.44M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 20.72M | 31.36M | 31.63M | -98.68M | -93.87M |
| Cash from Investing | 16.89M | 27.82M | 27.57M | -102.73M | -99.31M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -26.00K | -47.00K | -39.00K | -47.00K | -61.00K |
| Issuance of Common Stock | 3.95M | 5.88M | 9.59M | 119.46M | 128.92M |
| Repurchase of Common Stock | -2.06M | -2.06M | -4.05M | -4.05M | -4.77M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -311.00K | -768.00K | -768.00K |
| Cash from Financing | 1.86M | 3.78M | 5.18M | 114.59M | 123.32M |
| Foreign Exchange rate Adjustments | 3.00K | 6.00K | 15.00K | 0.00 | -9.00K |
| Miscellaneous Cash Flow Adjustments | -1.00K | -- | -- | -- | -- |
| Net Change in Cash | 3.24M | 12.95M | 15.95M | -4.61M | 7.05M |